Detalles de la búsqueda
1.
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Ann Intern Med;
177(2): 155-164, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252942
2.
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.
Oncologist;
2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484395
3.
Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer.
Breast Cancer Res Treat;
197(1): 223-233, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357711
4.
Racial and Ethnic Differences in Medication Initiation Among Adults Newly Diagnosed with Type 2 Diabetes.
J Gen Intern Med;
38(4): 994-1000, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35927604
5.
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Ann Intern Med;
175(10): 1392-1400, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191315
6.
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
J Gen Intern Med;
37(2): 415-438, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508290
7.
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis.
J Gen Intern Med;
37(2): 439-448, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850334
8.
Concurrent prescribing of opioids with other sedating medications after cancer diagnosis: a population-level analysis.
Support Care Cancer;
30(12): 9781-9791, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396793
9.
The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States.
Cancer;
127(1): 93-102, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119175
10.
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Oncologist;
26(9): 771-778, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33982829
11.
The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments.
J Gen Intern Med;
36(7): 1858-1866, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33904046
12.
Clinician burnout during the COVID-19 pandemic before vaccine administration.
J Am Pharm Assoc (2003);
61(5): e71-e77, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33962895
13.
New-onset persistent opioid use following breast cancer treatment in older adult women.
Cancer;
126(4): 814-822, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31846054
14.
The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherence.
Pharmacoepidemiol Drug Saf;
29(5): 550-557, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32196839
15.
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Oncologist;
24(5): 632-639, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30728276
16.
Using Group-based Trajectory Models and Propensity Score Weighting to Detect Heterogeneous Treatment Effects: The Case Study of Generic Hormonal Therapy for Women With Breast Cancer.
Med Care;
57(1): 85-93, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30489546
17.
Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
Am J Obstet Gynecol;
221(4): 318.e1-318.e9, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125544
18.
Web Exclusive. Annals On Call - First-Line Drug Therapy for Type 2 Diabetes.
Ann Intern Med;
176(2): eA220004, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802895
19.
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
Ann Intern Med;
176(4): eL230007, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068291
20.
Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis.
Ann Intern Med;
168(3): 170-178, 2018 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29230472